Birdwatch Archive

Birdwatch Note Rating

2024-11-29 02:03:56 UTC - HELPFUL

Rated by Participant: 8917F2CDB7A10EAB25718DAE83133DE7B8EC1EE5D4EFAF4227383087BBE179EA
Participant Details

Original Note:

The new rule proposal does not mandate Ozempic as an obesity treatment. The proposed rule changes a decades-old Medicare rule that prohibits the program from covering weight loss drugs. This makes Ozempic and other semaglutides available to those covered by Medicare. https://apnews.com/article/ozempic-biden-rfk-jr-trump-antiobesity-drugs-caaa2f888435af1d32bedb83e9ddbc0a

All Note Details

Original Tweet

All Information

  • noteId - 1862229962469658685
  • participantId -
  • raterParticipantId - 8917F2CDB7A10EAB25718DAE83133DE7B8EC1EE5D4EFAF4227383087BBE179EA
  • createdAtMillis - 1732845836218
  • version - 2
  • agree - 0
  • disagree - 0
  • helpful - 0
  • notHelpful - 0
  • helpfulnessLevel - HELPFUL
  • helpfulOther - 0
  • helpfulInformative - 0
  • helpfulClear - 1
  • helpfulEmpathetic - 0
  • helpfulGoodSources - 1
  • helpfulUniqueContext - 0
  • helpfulAddressesClaim - 1
  • helpfulImportantContext - 1
  • helpfulUnbiasedLanguage - 1
  • notHelpfulOther - 0
  • notHelpfulIncorrect - 0
  • notHelpfulSourcesMissingOrUnreliable - 0
  • notHelpfulOpinionSpeculationOrBias - 0
  • notHelpfulMissingKeyPoints - 0
  • notHelpfulOutdated - 0
  • notHelpfulHardToUnderstand - 0
  • notHelpfulArgumentativeOrBiased - 0
  • notHelpfulOffTopic - 0
  • notHelpfulSpamHarassmentOrAbuse - 0
  • notHelpfulIrrelevantSources - 0
  • notHelpfulOpinionSpeculation - 0
  • notHelpfulNoteNotNeeded - 0
  • ratingsId - 18622299624696586858917F2CDB7A10EAB25718DAE83133DE7B8EC1EE5D4EFAF4227383087BBE179EA